Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Participation at G20 Summit affirms Việt Nam's rising position, prestige in global arena: Diplomat 3.
State President sets off for official visits to Chile, Peru; attendance at APEC Economic Leaders’ Week 2.